CovidChloroV1, Main, Corpus, bibRecord, 000975

Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.

Identifieur interne : 000975 ( Main/Corpus ); précédent : 000974; suivant : 000976

Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.

Auteurs : Adrian V. Hernandez ; Yuani M. Roman ; Vinay Pasupuleti ; Joshuan J. Barboza ; C Michael White

Source :

Annals of internal medicine [ 1539-3704 ] ; 2020.

RBID : pubmed:33085507

English descriptors

KwdEn :
- COVID-19 (drug therapy), Chloroquine (MeSH), Coronavirus Infections (epidemiology), Humans (MeSH), Hydroxychloroquine (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), SARS-CoV-2 (MeSH).
MESH :
- chemical : Chloroquine, Hydroxychloroquine.
- drug therapy : COVID-19.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- Humans, Pandemics, SARS-CoV-2.

DOI: 10.7326/L20-1257
PubMed: 33085507
PubMed Central: PMC7596739

Links to Exploration step

pubmed:33085507

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.</title>
<author><name sortKey="Hernandez, Adrian V" sort="Hernandez, Adrian V" uniqKey="Hernandez A" first="Adrian V" last="Hernandez">Adrian V. Hernandez</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, School of Pharmacy, Storrs, Connecticut, and Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (A.V.H.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Roman, Yuani M" sort="Roman, Yuani M" uniqKey="Roman Y" first="Yuani M" last="Roman">Yuani M. Roman</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut (Y.M.R.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pasupuleti, Vinay" sort="Pasupuleti, Vinay" uniqKey="Pasupuleti V" first="Vinay" last="Pasupuleti">Vinay Pasupuleti</name>
<affiliation><nlm:affiliation>MedErgy HealthGroup, Yardley, Pennsylvania (V.P.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Barboza, Joshuan J" sort="Barboza, Joshuan J" uniqKey="Barboza J" first="Joshuan J" last="Barboza">Joshuan J. Barboza</name>
<affiliation><nlm:affiliation>Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (J.J.B.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="White, C Michael" sort="White, C Michael" uniqKey="White C" first="C Michael" last="White">C Michael White</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, and School of Pharmacy, Storrs, Connecticut (C.M.W.).</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33085507</idno>
<idno type="pmid">33085507</idno>
<idno type="doi">10.7326/L20-1257</idno>
<idno type="pmc">PMC7596739</idno>
<idno type="wicri:Area/Main/Corpus">000975</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000975</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.</title>
<author><name sortKey="Hernandez, Adrian V" sort="Hernandez, Adrian V" uniqKey="Hernandez A" first="Adrian V" last="Hernandez">Adrian V. Hernandez</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, School of Pharmacy, Storrs, Connecticut, and Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (A.V.H.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Roman, Yuani M" sort="Roman, Yuani M" uniqKey="Roman Y" first="Yuani M" last="Roman">Yuani M. Roman</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut (Y.M.R.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pasupuleti, Vinay" sort="Pasupuleti, Vinay" uniqKey="Pasupuleti V" first="Vinay" last="Pasupuleti">Vinay Pasupuleti</name>
<affiliation><nlm:affiliation>MedErgy HealthGroup, Yardley, Pennsylvania (V.P.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Barboza, Joshuan J" sort="Barboza, Joshuan J" uniqKey="Barboza J" first="Joshuan J" last="Barboza">Joshuan J. Barboza</name>
<affiliation><nlm:affiliation>Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (J.J.B.).</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="White, C Michael" sort="White, C Michael" uniqKey="White C" first="C Michael" last="White">C Michael White</name>
<affiliation><nlm:affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, and School of Pharmacy, Storrs, Connecticut (C.M.W.).</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of internal medicine</title>
<idno type="eISSN">1539-3704</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (drug therapy)</term>
<term>Chloroquine (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33085507</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1539-3704</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>173</Volume>
<Issue>11</Issue>
<PubDate><Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Annals of internal medicine</Title>
<ISOAbbreviation>Ann Intern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>W156-W157</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7326/L20-1257</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hernandez</LastName>
<ForeName>Adrian V</ForeName>
<Initials>AV</Initials>
<Identifier Source="ORCID">0000-0002-9999-4003</Identifier>
<AffiliationInfo><Affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, School of Pharmacy, Storrs, Connecticut, and Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (A.V.H.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roman</LastName>
<ForeName>Yuani M</ForeName>
<Initials>YM</Initials>
<AffiliationInfo><Affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut (Y.M.R.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pasupuleti</LastName>
<ForeName>Vinay</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>MedErgy HealthGroup, Yardley, Pennsylvania (V.P.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barboza</LastName>
<ForeName>Joshuan J</ForeName>
<Initials>JJ</Initials>
<Identifier Source="ORCID">0000-0002-2896-1407</Identifier>
<AffiliationInfo><Affiliation>Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru (J.J.B.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>White</LastName>
<ForeName>C Michael</ForeName>
<Initials>CM</Initials>
<Identifier Source="ORCID">0000-0002-9367-4893</Identifier>
<AffiliationInfo><Affiliation>University of Connecticut Health Outcomes, Policy, and Evidence Synthesis Group and Hartford Hospital Department of Research Administration, Hartford, Connecticut, and School of Pharmacy, Storrs, Connecticut (C.M.W.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>10</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Ann Intern Med</MedlineTA>
<NlmUniqueID>0372351</NlmUniqueID>
<ISSNLinking>0003-4819</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Ann Intern Med. 2020 Aug 18;173(4):287-296</RefSource>
<PMID Version="1">32459529</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>15</Hour>
<Minute>35</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33085507</ArticleId>
<ArticleId IdType="doi">10.7326/L20-1257</ArticleId>
<ArticleId IdType="pmc">PMC7596739</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Eur J Intern Med. 2020 Dec;82:38-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32859477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Trop Med Hyg. 2020 Oct;103(4):1635-1639</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32828135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2020 Aug;97:396-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32623082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409486</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Oct 6;173(7):W128-W129</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32853033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 16;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32674126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med (N Y). 2020 Dec 18;1(1):114-127.e3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32838355</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2020 Jul 11;24(1):418</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32653015</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jun 18;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32556143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Glob Antimicrob Resist. 2020 Sep;22:842-844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32763357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Oct;56(4):106144</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32853673</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Aug 18;173(4):287-296</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32459529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32391667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Aug 18;173(4):W78-W79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32667853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Nov 19;383(21):2041-2052</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci China Life Sci. 2020 Oct;63(10):1515-1521</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32418114</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000975 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000975 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33085507
   |texte=   Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33085507" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.

Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki